AstraZeneca hit by patent expiries as sales slump
Drugmaker AstraZeneca has showed it is still languishing in intensive care after patent expiries triggered an 8 per per cent fall in sales to $25.7
Despite new chief executive Pascal Soriot’s recent string of acquisitions to boost Astra’s pipeline, the pharmaceuticals giant admitted that it expects revenues to fall again this year by “a low-to-mid-single-digit percentage”.
Astra is suffering from blockbuster drugs, including cholesterol-buster Crestor and heartburn and ulcer treatment Nexium, facing cheaper, generic competition in Australia and Europe respectively.
Those patent expiries, as well as the cost of acquisitions, including spending up to $4.1 billion buying out rival Bristol-Myers Squibb’s stake in a diabetes-medicine development venture, saw Astra’s pre-tax profit crash 57 per cent to $3.3 billion in 2013.
In the crucial United States market, Astra’s revenues fell 7 per cent in the last three months of 2013, while in Europe, where treatments including anti-psychotic drug Seroquel IR dropped out of patent, sales lost 2 per cent in the same period.
The US picture is set to worsen this year: from May, Nexium will face generic competition. Astra admitted that US healthcare reforms, which force drugmakers to pay annual fees, had cost $318 million in the fourth quarter.
Soriot, who has cut Astra’s headcount by more than 11,000 over two years, said: “Our financial performance for 2013 reflects the ongoing impact from the loss of exclusivity for several key brands. In the near term these headwinds will remain challenging, however I am confident that we can return to growth… and expect our 2017 revenues will be broadly in line with 2013.”
He also said Astra’s late-stage pipeline of drugs that are close to being put forward for regulatory approval has nearly doubled.
The shares fell 3.5%, or 135.5p, to 3741.5p.
- 1 Russell Brand accuses FOX News anchor Sean Hannity of terrorism after aggressive Israel-Gaza debate
- 2 Pope Francis issues top 10 tips for happiness – including don’t try to convert other people
- 3 Arturo Vidal to Manchester United: Midfielder set to force through move to Louis van Gaal's Red Devils - reports
- 4 Disney heiress Abigail disowns her share of family profits in West Bank company
- 5 Israel's propaganda machine is finally starting to misfire
Russell Brand accuses FOX News anchor Sean Hannity of terrorism after aggressive Israel-Gaza debate
Pope Francis issues top 10 tips for happiness – including don’t try to convert other people
Sabina Altynbekova, the girl branded 'too good looking' for volleyball, says social media obsession with her is a 'bit much'
Justin Bieber posts Instagram photo of Orlando Bloom crying after Ibiza fight 'over Miranda Kerr'
Disney heiress Abigail disowns her share of family profits in West Bank company
The secret report that helps Israel hide facts
Land for gas: Merkel and Putin discussed secret deal could end Ukraine crisis
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
Richard Dawkins tweets: 'Date rape is bad, stranger rape is worse'
Putin is 'thuggish, dishonest and reckless', says British ambassador to US
Boozy, ignorant, intolerant, but very polite – Britain as others see us
- < Previous
- Next >
iJobs Money & Business
£20000 - £24000 per annum: Harrington Starr: A leading provider of web based m...
£28000 - £32000 per annum: Ashdown Group: Secretary (Sales Team Support) - Mat...
Competitive (DOE): Guru Careers: We are looking for an Assistant Management Ac...
£600 - £700 per day + competitive: Orgtel: Senior Investment Accounting Change...